Updated: January 28, 2026
How to Help Your Patients Save Money on Estradiol/Norgestimate (Prefest): A Provider's Guide to Savings Programs
Author
Peter Daggett

Summarize with AI
- Understanding the Cost Landscape for Prefest
- Strategy 1: Manufacturer Patient Assistance Programs
- Strategy 2: Insurance Optimization — Prior Authorization and Tier Exception
- Strategy 3: Clinical Switching to a Generic Alternative
- Strategy 4: Point Patients to Discount Card Resources
- Medicare Patients: Special Considerations
- The Bottom Line
A clinical guide for providers on helping patients reduce the cost of Prefest (Estradiol/Norgestimate) through insurance, manufacturer programs, and generics.
Prefest (Estradiol/Norgestimate) is a brand-name-only HRT with no generic equivalent, carrying a retail cash price of approximately $190–$230 per month. For many patients — particularly those on Medicare, high-deductible health plans, or limited incomes — this cost can create a significant barrier to adherence. As a provider, understanding the available cost-reduction pathways puts you in a position to help. This guide covers the key resources and strategies.
Understanding the Cost Landscape for Prefest
Because Prefest has no generic, the cost-reduction levers are more limited than for generic HRT products — but they exist. Here's a summary of the pricing landscape:
- Retail cash price: ~$190–$230 per 30-tablet blister card (1-month supply).
- GoodRx coupon price: Approximately $202 — a modest 8% discount, reflecting the limited competition for brand-only products.
- Commercial insurance copay: Typically Tier 2 or Tier 3; copays vary from $30–$80/month, though prior authorization may be required.
- Medicare Part D: Most plans cover Prefest; cost-sharing varies by plan tier and phase of coverage. In 2026, Medicare Part D has a $2,100 annual out-of-pocket cap, which protects patients from unlimited drug spending.
Strategy 1: Manufacturer Patient Assistance Programs
Teva Pharmaceuticals, the manufacturer of Prefest, operates patient assistance programs that may provide free or low-cost medication to eligible patients who are uninsured or underinsured. As a provider, you can facilitate access by:
- Checking NeedyMeds.org (needymeds.org) for current Teva assistance programs for Prefest. NeedyMeds maintains an updated database of manufacturer programs.
- Contacting Teva's patient services line directly or visiting their website for copay assistance card availability for commercially insured patients.
- Designating a staff member in your practice to assist patients with paperwork for assistance program applications — this significantly increases uptake and adherence.
Note: Manufacturer copay cards typically cannot be used by patients with federal insurance programs (Medicare, Medicaid, TRICARE). For those patients, other strategies below are more relevant.
Strategy 2: Insurance Optimization — Prior Authorization and Tier Exception
When a patient's insurance plan places Prefest in a high tier or requires prior authorization (PA), your team can reduce their cost through:
- Prior authorization submission: Document the clinical indication, prior treatment history (if any), and reason for choosing Prefest over lower-cost alternatives. Most insurers approve PAs for appropriate menopausal HRT indications.
- Tier exception request: If there is a clinical reason why a lower-tier alternative is not appropriate for a specific patient (e.g., documented intolerance to other progestins), you can submit a tier exception request to have Prefest covered at a lower cost-sharing tier.
- 90-day supply prescription: Most insurance plans offer a lower per-dose copay for 90-day mail-order fills than 30-day retail fills. Writing for 90-day supplies is a simple, high-impact intervention.
Strategy 3: Clinical Switching to a Generic Alternative
When cost is the primary barrier and there is no clinical reason to use Prefest specifically, switching to a generic alternative is the most impactful cost-reduction strategy. Generic options with equivalent therapeutic profiles include:
- Generic estradiol/norethindrone acetate (Activella generic): Most clinically similar to Prefest; same bioidentical estradiol; generic available at approximately $20–$60/month with a discount card. Requires a new prescription.
- Generic Prempro (CE/MPA): Widely available; generic copay typically $10–$30 with most commercial insurance; cash price as low as $30–$70 with discount card. Uses conjugated estrogens rather than bioidentical estradiol.
- Oral estradiol + micronized progesterone (Prometrium generic): Bioidentical option; allows independent dose titration of each component; combined monthly cost typically $15–$40 with generic discount cards.
For patients who specifically benefit from the intermittent progestogen feature of Prefest (e.g., patients with progestin-related side effects on continuous combined therapy), this clinical rationale should be documented to support prior authorization for the brand product.
Strategy 4: Point Patients to Discount Card Resources
For patients paying out-of-pocket or with very high insurance copays, prescription discount cards can provide meaningful savings even for brand-name medications. Recommend:
- GoodRx: goodrx.com — shows Prefest prices at pharmacies in the patient's area; coupon available on the website or app. Current price ~$202.
- NeedyMeds: needymeds.org — comprehensive database of manufacturer assistance programs, disease funds, and government programs.
- Partnership for Prescription Assistance (PPA): pparx.org — connects patients to assistance programs based on their situation.
Medicare Patients: Special Considerations
Medicare patients face unique considerations for Prefest costs:
- Manufacturer copay cards are not usable with Medicare — this is a legal restriction under federal anti-kickback statutes.
- Medicare Part D's $2,100 annual out-of-pocket cap (2026) provides a safety net for high-cost medications.
- The Medicare Prescription Payment Plan (2025+) allows patients to spread out-of-pocket costs over the year rather than paying upfront.
- Encouraging Medicare patients to compare Part D formularies during open enrollment (October 15 – December 7) can identify plans with better Prefest coverage.
The Bottom Line
Helping patients manage the cost of Prefest requires a layered approach: manufacturer assistance for uninsured patients, insurance optimization for commercially insured patients, generic alternatives when clinically appropriate, and directing all patients to discount card resources. As a provider, integrating these conversations into your standard prescribing workflow reduces cost-driven non-adherence and improves outcomes. For tools to help your patients find Prefest at pharmacies near them, see medfinder for providers.
Frequently Asked Questions
Teva Pharmaceuticals offers patient assistance programs that may provide free or reduced-cost Prefest to eligible patients. Check NeedyMeds.org for current programs. Manufacturer copay cards, when available, typically apply to commercially insured patients only — they cannot be used with Medicare, Medicaid, or other federal insurance programs.
Prior authorization (PA) is typically required when an insurer needs documentation of medical necessity before covering a brand-name drug. Submitting a PA with clear clinical indication documentation often results in approval. If PA is denied, a peer-to-peer review with the medical director may be helpful, particularly if lower-tier alternatives were trialed unsuccessfully.
Generic estradiol/norethindrone acetate (the generic for Activella) is the most clinically similar and often most cost-effective alternative — typically $20–$60/month with discount cards like GoodRx, compared to $200+ for Prefest. Generic Prempro is also widely available at $30–$70/month. Both require a new prescription as they cannot be substituted at the pharmacy counter for Prefest.
The 2026 Medicare Part D $2,100 annual out-of-pocket cap means that once a patient has paid $2,100 in qualifying drug costs during the year, their plan covers 100% of covered medications for the remainder of the year. For patients on multiple brand-name drugs including Prefest, this cap can provide meaningful financial protection in the second half of the year.
Yes, and it's often one of the simplest interventions. Most commercial and Medicare Part D plans offer a lower per-dose copay for 90-day mail-order fills than 30-day retail fills. A 90-day mail-order supply can reduce the patient's monthly effective cost by 20–50% depending on the plan design, while also reducing how often they need to fill.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Estradiol/Norgestimate also looked for:
More about Estradiol/Norgestimate
34,034 have already found their meds with Medfinder.
Start your search today.





